Why did Latrepirdine Fail in Phase III Studies? There are several plausible explanations for the failure of latrepirdine in Phase III trials despite promising Phase II data. The three most likely ...

Robust preclinical in vitro and in vivo data indicate that latrepirdine has a protective effect regarding pathological changes in Alzheimer's disease. Speculation regarding mechanisms of action ...